Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study
Vollenberg R, Tepasse PR, Lorentzen E, Nowacki T
Research article (journal) | Peer reviewedDetails about the publication
Journal: Journal of personalized medicine
Volume: 12
Status: Published
Release year: 2022 (26/04/2022)
Language in which the publication is written: English
DOI: 10.3390/jpm12050694
Keywords: SARS-CoV-2; COVID-19; vaccination; IBD patients; seroconversion; humoral and; T-cellular immune response
Authors from the University of Münster
| Lorentzen, Eva | Institute of Molecular Virology |
| Nowacki, Tobias Max | Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B) |
| Tepasse, Phil-Robin | Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B) |
| Vollenberg, Richard | Medical Clinic of Internal Medicine B: Gastroenterology and Metabolic Disorders (Med B) |